Thymulin

Thymulin (Facteur Thymique Sérique)

Evidence & Status

  • Preliminary / Experimental
  • Preliminary

At a Glance

A zinc-dependent nonapeptide secreted exclusively by thymic epithelial cells, essential for promoting T-cell maturation and differentiation. Studied as both a marker and potential therapeutic target in immune aging research, given its documented decline alongside age-related thymic involution.

Plain English

Researchers study Thymulin because it is the thymus gland's own signaling molecule for training immature immune cells to become functional T cells — and it requires zinc to be biologically active, which is an unusual feature. Scientists are interested in it primarily because thymulin levels fall significantly as the thymus shrinks with age, potentially contributing to the weakened cellular immunity observed in older adults. Research explores whether restoring thymulin signaling could support immune function in aging, and it serves as a measurable biological marker of thymic activity.

Overview

A zinc-dependent nonapeptide hormone secreted exclusively by thymic epithelial cells. Requires complexation with zinc for biological activity. Primary function is promoting T-cell differentiation and maturation within the thymus — particularly the transition from immature double-negative T cells to mature T helper and cytotoxic T lymphocytes. Thymulin levels decline with age alongside thymic involution, making it a marker and potential target of immune aging. Structurally and functionally distinct from thymosin alpha-1 and the thymalin peptide fraction.

Research Summary

Thymulin (FTS, facteur thymique sérique) is a zinc-dependent thymic nonapeptide involved in T-cell biology. It is distinct from thymalin, a thymic peptide fraction, and thymosin alpha-1/thymalfasin, a different peptide. Human evidence includes historical randomized, double-blind research with synthetic thymulin/nonathymulin in rheumatoid arthritis and separate work measuring endogenous thymulin; these findings do not establish modern therapeutic efficacy or routine clinical use. Animal and laboratory findings remain research context, while human dosing, pharmacokinetics, and safety are not established.

Research Areas

  • T-cell maturation and differentiation
  • Immune aging and thymic involution
  • Zinc-dependent immune regulation
  • Anti-inflammatory effects
  • Immunosenescence

Safety & Risks

Serious Risks

  • Insufficient human safety data
  • Potential immune stimulation concerns in autoimmune conditions
  • Zinc requirement adds pharmacokinetic complexity

Reported Side Effects

  • Not well-characterized; generally well-tolerated in preliminary studies
  • Potential zinc-related effects at high doses
United States
Research only
United Kingdom
Research only
Australia
Research only
Canada
Research only

Citations & Sources